Gujarat Narmada Valley Fert Chem Share Price
Sector: Chemical Manufacturing
552.65 +0.60 (0.11%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
547.10
Today’s High
559.80
52 Week Low
448.90
52 Week High
776.60
552.50 +0.40 (0.07%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
546.75
Today’s High
559.60
52 Week Low
449.00
52 Week High
776.60
Key Metrics
- Market Cap (In Cr) 8123.61
- Beta 1.26
- Div. Yield (%) 3.26
- P/B 0.95
- TTM P/E 12.22
- Peg Ratio -0.48
- Sector P/E 17.82
- D/E 0
- Open Price 550.4
- Prev Close 552.05
Gujarat Narmada Valley Fert Chem Analysis
Price Analysis
-
1 Week0.14%
-
3 Months11.81%
-
6 Month-12.16%
-
YTD-1.23%
-
1 Year-17.23%
Risk Meter
- 35% Low risk
- 35% Moderate risk
- 35% Balanced Risk
- 35% High risk
- 35% Extreme risk
Gujarat Narmada Valley Fert Chem News
Jay Thakkar of ICICI Sec recommends these 3 shares to buy in F&O segment
6 min read . 05 Feb 2025Technical Picks:Nagaraj Shetti suggests 2 stocks to buy in a rising stock market
2 min read . 20 Jan 2025NSE to exclude PVR INOX, 15 other securities from F&O effective February 28
1 min read . 20 Dec 2024Gujarat Narmada Valley Fert Chem Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 7892
- Selling/ General/ Admin Expenses Total
- 2016
- Depreciation/ Amortization
- 303
- Other Operating Expenses Total
- 731
- Total Operating Expense
- 7580
- Operating Income
- 312
- Net Income Before Taxes
- 790
- Net Income
- 597
- Diluted Normalized EPS
- 40.61
- Period
- 2025
- Total Assets
- 11003
- Total Liabilities
- 2428
- Total Equity
- 8575
- Tangible Book Valueper Share Common Eq
- 580.57
- Period
- 2025
- Cashfrom Operating Activities
- 606
- Cashfrom Investing Activities
- -466
- Cashfrom Financing Activities
- -262
- Net Changein Cash
- -122
- Period
- 2024
- Total Revenue
- 7929.73
- Selling/ General/ Admin Expenses Total
- 2613.99
- Depreciation/ Amortization
- 306.73
- Other Operating Expenses Total
- 48.37
- Total Operating Expense
- 7716.53
- Operating Income
- 213.2
- Net Income Before Taxes
- 651.11
- Net Income
- 497.06
- Diluted Normalized EPS
- 32.77
- Period
- 2024
- Total Assets
- 10671.87
- Total Liabilities
- 2363.11
- Total Equity
- 8308.76
- Tangible Book Valueper Share Common Eq
- 564.32
- Period
- 2024
- Cashfrom Operating Activities
- 31.28
- Cashfrom Investing Activities
- 1235.49
- Cashfrom Financing Activities
- -1280.96
- Net Changein Cash
- -14.19
- Period
- 2023
- Total Revenue
- 10226.93
- Selling/ General/ Admin Expenses Total
- 3043.78
- Depreciation/ Amortization
- 302.13
- Other Operating Expenses Total
- 46.36
- Total Operating Expense
- 8636.13
- Operating Income
- 1590.8
- Net Income Before Taxes
- 1931.55
- Net Income
- 1471.54
- Diluted Normalized EPS
- 94.77
- Period
- 2023
- Total Assets
- 11695.53
- Total Liabilities
- 2590.42
- Total Equity
- 9105.11
- Tangible Book Valueper Share Common Eq
- 584.65
- Period
- 2023
- Cashfrom Operating Activities
- 1373.08
- Cashfrom Investing Activities
- -1229.43
- Cashfrom Financing Activities
- -160.1
- Net Changein Cash
- -16.45
- Period
- 2022
- Total Revenue
- 8642.29
- Selling/ General/ Admin Expenses Total
- 1992.31
- Depreciation/ Amortization
- 291.27
- Other Operating Expenses Total
- 31.78
- Total Operating Expense
- 6536.78
- Operating Income
- 2105.51
- Net Income Before Taxes
- 2298.05
- Net Income
- 1710.41
- Diluted Normalized EPS
- 110.14
- Period
- 2022
- Total Assets
- 10734.39
- Total Liabilities
- 2744.36
- Total Equity
- 7990.03
- Tangible Book Valueper Share Common Eq
- 512.81
- Period
- 2022
- Cashfrom Operating Activities
- 1966.66
- Cashfrom Investing Activities
- -1898.76
- Cashfrom Financing Activities
- -130.27
- Net Changein Cash
- -62.37
- Period
- 2021
- Total Revenue
- 5128.69
- Selling/ General/ Admin Expenses Total
- 1563.24
- Depreciation/ Amortization
- 271.87
- Other Operating Expenses Total
- 23.05
- Total Operating Expense
- 4382.84
- Operating Income
- 745.85
- Net Income Before Taxes
- 948.31
- Net Income
- 696.95
- Diluted Normalized EPS
- 45
- Period
- 2021
- Total Assets
- 8384.81
- Total Liabilities
- 2316.61
- Total Equity
- 6068.2
- Tangible Book Valueper Share Common Eq
- 389.08
- Period
- 2021
- Cashfrom Operating Activities
- 1884.4
- Cashfrom Investing Activities
- -855.81
- Cashfrom Financing Activities
- -933.66
- Net Changein Cash
- 94.93
- Period
- 2020
- Total Revenue
- 5162.42
- Selling/ General/ Admin Expenses Total
- 1659.79
- Depreciation/ Amortization
- 263.91
- Other Operating Expenses Total
- 34.37
- Total Operating Expense
- 4871.92
- Operating Income
- 290.5
- Net Income Before Taxes
- 424.83
- Net Income
- 508.01
- Diluted Normalized EPS
- 24.91
- Period
- 2020
- Total Assets
- 8418.66
- Total Liabilities
- 3119.37
- Total Equity
- 5299.29
- Tangible Book Valueper Share Common Eq
- 339.52
- Period
- 2020
- Cashfrom Operating Activities
- 285.73
- Cashfrom Investing Activities
- -900.91
- Cashfrom Financing Activities
- 546.02
- Net Changein Cash
- -69.16
- Period
- 2019
- Total Revenue
- 5896.02
- Selling/ General/ Admin Expenses Total
- 1916.56
- Depreciation/ Amortization
- 262.52
- Other Operating Expenses Total
- 26.25
- Total Operating Expense
- 5272.03
- Operating Income
- 623.99
- Net Income Before Taxes
- 819.36
- Net Income
- 749.74
- Diluted Normalized EPS
- 48.74
- Period
- 2019
- Total Assets
- 7609.24
- Total Liabilities
- 2544.51
- Total Equity
- 5064.73
- Tangible Book Valueper Share Common Eq
- 324.29
- Period
- 2019
- Cashfrom Operating Activities
- 541.15
- Cashfrom Investing Activities
- -150.27
- Cashfrom Financing Activities
- -184.93
- Net Changein Cash
- 205.95
- Period
- 2025-03-31
- Total Revenue
- 2055
- Selling/ General/ Admin Expenses Total
- 507
- Depreciation/ Amortization
- 74
- Other Operating Expenses Total
- 187
- Total Operating Expense
- 1889
- Operating Income
- 166
- Net Income Before Taxes
- 287
- Net Income
- 211
- Diluted Normalized EPS
- 14.35
- Period
- 2025-03-31
- Total Assets
- 11003
- Total Liabilities
- 2428
- Total Equity
- 8575
- Tangible Book Valueper Share Common Eq
- 580.57
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 606
- Cashfrom Investing Activities
- -466
- Cashfrom Financing Activities
- -262
- Net Changein Cash
- -122
- Period
- 2024-12-31
- Total Revenue
- 1899
- Selling/ General/ Admin Expenses Total
- 521
- Depreciation/ Amortization
- 75
- Other Operating Expenses Total
- 194
- Total Operating Expense
- 1842
- Operating Income
- 57
- Net Income Before Taxes
- 211
- Net Income
- 163
- Diluted Normalized EPS
- 11.09
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1917
- Selling/ General/ Admin Expenses Total
- 470
- Depreciation/ Amortization
- 76
- Other Operating Expenses Total
- 172
- Total Operating Expense
- 1903
- Operating Income
- 14
- Net Income Before Taxes
- 135
- Net Income
- 105
- Diluted Normalized EPS
- 7.14
- Period
- 2024-09-30
- Total Assets
- 10846
- Total Liabilities
- 2475
- Total Equity
- 8371
- Tangible Book Valueper Share Common Eq
- 566.56
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 311
- Cashfrom Investing Activities
- -163
- Cashfrom Financing Activities
- -249
- Net Changein Cash
- -101
- Period
- 2024-06-30
- Total Revenue
- 2021
- Selling/ General/ Admin Expenses Total
- 518
- Depreciation/ Amortization
- 78
- Other Operating Expenses Total
- 178
- Total Operating Expense
- 1946
- Operating Income
- 75
- Net Income Before Taxes
- 157
- Net Income
- 118
- Diluted Normalized EPS
- 8.03
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 2109.73
- Selling/ General/ Admin Expenses Total
- 528.16
- Depreciation/ Amortization
- 77.54
- Other Operating Expenses Total
- 206.41
- Total Operating Expense
- 2043.3
- Operating Income
- 66.43
- Net Income Before Taxes
- 171.11
- Net Income
- 130.06
- Diluted Normalized EPS
- 8.83
- Period
- 2024-03-31
- Total Assets
- 10671.87
- Total Liabilities
- 2363.11
- Total Equity
- 8308.76
- Tangible Book Valueper Share Common Eq
- 564.32
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 31.28
- Cashfrom Investing Activities
- 1235.49
- Cashfrom Financing Activities
- -1280.96
- Net Changein Cash
- -14.19
- Period
- 2023-12-31
- Total Revenue
- 2088
- Selling/ General/ Admin Expenses Total
- 558
- Depreciation/ Amortization
- 76
- Other Operating Expenses Total
- 194
- Total Operating Expense
- 2080
- Operating Income
- 8
- Net Income Before Taxes
- 122
- Net Income
- 97
- Diluted Normalized EPS
- 6.3
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Gujarat Narmada Valley Fert Chem Technical
Moving Average
SMA
- 5 Day549.33
- 10 Day545.74
- 20 Day527.18
- 50 Day506.39
- 100 Day518.82
- 300 Day573.77
Gujarat Narmada Valley Fert Chem Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Galaxy Surfactants
- 2451.5
- -7.45
- -0.3
- 3366.3
- 2025
- 8670.4
- Gujarat State Fertilizers And Ch
- 211.65
- 1.4
- 0.67
- 274.5
- 156.5
- 8433.78
- Gujarat Narmada Valley Fert Chem
- 552.65
- 0.6
- 0.11
- 776.6
- 448.9
- 8123.61
- Epigral
- 1824.05
- 10.95
- 0.6
- 2408.35
- 1298.8
- 7825.9
- Dhanuka Agritech
- 1684.5
- -5.2
- -0.31
- 1926.4
- 1091.6
- 7593.44
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Galaxy Surfactants
- 28.1
- 3.63
- 17.94
- 8.19
- Gujarat State Fertilizers And Ch
- 14.28
- 0.7
- 6.82
- 8.06
- Gujarat Narmada Valley Fert Chem
- 13.63
- 0.95
- 12.95
- 12.37
- Epigral
- 21.69
- 4.16
- 25.32
- 13.93
- Dhanuka Agritech
- 25.78
- 5.43
- 23.18
- 14.22
Gujarat Narmada Valley Fert Chem Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 23-May-25
- Audited Results & Final Dividend
- 14-Feb-25
- Quarterly Results
- 13-Nov-24
- Quarterly Results
- 11-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 28-May-24
- Audited Results & Final Dividend
- 07-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results & Buy Back of Shares
- 07-Aug-23
- Quarterly Results
- 18-May-23
- Audited Results & Final Dividend
- Meeting Date
- Announced on
- Purpose
- 07-Apr-25
- 03-Mar-25
- POM
- 04-Mar-25
- 27-Jan-25
- POM
- 20-Sept-24
- 27-Aug-24
- AGM
- 13-Apr-24
- 11-Mar-24
- POM
- 09-Nov-23
- 09-Oct-23
- POM
- 26-Sept-23
- 23-Aug-23
- AGM
- 18-Apr-23
- 13-Mar-23
- POM
- 24-May-22
- 12-Apr-22
- POM
- 23-Sept-21
- 03-Aug-21
- AGM
- -
- 08-Nov-23
- Others
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 23-May-25
- -
- -
- 18
- 28-May-24
- 06-Sept-24
- 06-Sept-24
- 16.5
- 18-May-23
- -
- 18-Sept-23
- 30
- 19-May-21
- -
- 18-Aug-21
- 8


